Full biographies of the Novo Nordisk leadership team may be found here .
Earlier today, Novo Nordisk released its 2012 earnings statement, highlighting 43 consecutive quarters of double digit growth. The U.S. now contributes more than 40% (42%) to the company's global revenues.
About Novo NordiskHeadquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com. For more information about our U.S. activities, follow us on Twitter at @NovoNordiskUS.
SOURCE Novo Nordisk
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts